NCI Announces New Cancer Survivorship Training Program

Publication
Article
OncologyONCOLOGY Vol 12 No 2
Volume 12
Issue 2

In response to the difficult and complex issues affecting cancer survivors, the National Cancer Institute (NCI) has created a new training program, The Cancer Journey: Issues for Survivors. It is designed for health professionals in training roles to educate their peers about the many issues survivors face.

In response to the difficult and complex issues affecting cancer survivors, the National Cancer Institute (NCI) has created a new training program, The Cancer Journey: Issues for Survivors. It is designed for health professionals in training roles to educate their peers about the many issues survivors face.

The training program was developed by NCI’s Office of Cancer Information, Communication, and Education in collaboration with Ortho Biotech Inc., the National Coalition for Cancer Survivorship, and cancer organizations nationwide.

To obtain a free copy of the training program, please contact the NCI’s Cancer Information Service at 1 (800) 4-CANCER [1 (800) 422-6237].

Articles in this issue
New Tobacco Industry Strategy Is to Appear Anti-Tobacco, UCSF Study Concludes
Quantitative Assay Provides Effective Method for Monitoring Bladder Cancer
Extension of Human Cell Life-Span Reported
Abnormal DNA Structures May Hold Key to Early Cancer Detection, Treatment
SGO Clinical Practice Guidelines: Introductory Remarks
ACS Issues Action Proposal on Prostate Cancer in African-Americans
HMO vs Fee-for-Service Care for Breast Cancer
Revised Manual on Radiation Oncology Nursing Available
ONS Publishes Manual on Psychosocial Aspects of Oncology Care
Cigarette Smoking Among Adults-United States, 1995
NCI Announces New Cancer Survivorship Training Program
Carmustine Wafer to Be Studied in Newly Diagnosed Malignant Glioma
Thyroid Cancer May Not Be More Serious in Pregnant Women
Beyond Survival: Economic Analyses of Chemotherapy in Advanced, Inoperable NSCLC
Practice Guidelines: Fallopian Tube Cancer
Recent Videos
Additional local, regional, or national policy may bolster access to screening for colorectal cancer, according to Aasma Shaukat, MD, MPH.
3 experts are featured in this series.
3 experts are featured in this series.
The mechanism of action for daraxonrasib inhibits effectors and signaling while forming a relatively unstable tri-complex with codon 12 mutations.
4 experts are featured in this series.
6 experts are featured in this series.
Related Content
Clonal hematopoiesis may be associated with the early development of toxic events in patients with newly diagnosed multiple myeloma.

CHIP-Carrying Multiple Myeloma Correlates With More Aggressive Disease

Roman Fabbricatore
February 4th 2025
Article

Clonal hematopoiesis may be associated with the early development of toxic events in patients with newly diagnosed multiple myeloma.

Expanding and Advancing the Future of Renal Cell Carcinoma Treatment

Expanding and Advancing the Future of Renal Cell Carcinoma Treatment

Eric Jonasch, MD
February 3rd 2025
Podcast

Eric Jonasch, MD, believes that the Kidney Cancer Research Consortium may broaden their reach to provide care to many different groups of patients.

Support for the recommendation is based on phase 3 ADRIATIC trial results showing a 27% reduction in the risk of death with durvalumab vs placebo.

CHMP Recommends EU Approval for Durvalumab in Limited-Stage SCLC

Roman Fabbricatore
February 4th 2025
Article

Support for the recommendation is based on phase 3 ADRIATIC trial results showing a 27% reduction in the risk of death with durvalumab vs placebo.

Shwetal Mehta, PhD, emphasizes her institution’s patient-focused and scientifically rigorous philosophy when developing new therapies in brain cancer.

Conducting Early Phase Trials of Promising Treatments in Neuro-Oncology

Shwetal Mehta, PhD
January 27th 2025
Podcast

Shwetal Mehta, PhD, emphasizes her institution’s patient-focused and scientifically rigorous philosophy when developing new therapies in brain cancer.

Integrative Oncology Approaches to Managing Gastrointestinal Cancer

Integrative Oncology Approaches to Managing Gastrointestinal Cancer

Ariana Pelosci
February 4th 2025
Article

Options like acupuncture or cannabis use may be viable to help manage symptoms related to gastrointestinal cancer treatment.

Encorafenib Combo Improves PFS in Metastatic Colorectal Cancer

Encorafenib Combo Improves PFS in Metastatic Colorectal Cancer

Tim Cortese
February 3rd 2025
Article

Full progression-free survival results for patients with BRAF V600E mCRC from the phase 3 BREAKWATER trial will be presented at an upcoming medical conference.